Feature | Thrombosis and COVID-19: FAQs For Current Practice

Geoffrey D. Barnes; Adam Cuker; Tyler J Gluckman; Gregory Piazza; Deborah M. Siegal

Feature | Thrombosis and COVID-19: FAQs For Current Practice

Geoffrey D. Barnes, Adam Cuker, Tyler J Gluckman, Gregory Piazza, Deborah M. Siegal

Center for Cardiovascular Analytics, Research and Data Science (CARDS)

Research output: Other contribution

Abstract

An FAQ on the potential impact of COVID-19 on thrombotic and/or bleeding risk from ACC's Science and Quality Committee summarize the current data on the risk, potential need for hemostasis/coagulation testing, VTE prophylaxis, and therapeutic anticoagulation in patients with COVID-19 without confirmed/suspected thrombosis.

Original language	Undefined/Unknown
State	Published - Apr 22 2020

Publication series

Name	Articles, Abstracts, and Reports

Access to Document

http://digitalcommons.providence.org/publications/3952

Cite this

@misc{802239b7f439452fb2bdbb8f2199913f,

title = "Feature | Thrombosis and COVID-19: FAQs For Current Practice",

abstract = "An FAQ on the potential impact of COVID-19 on thrombotic and/or bleeding risk from ACC's Science and Quality Committee summarize the current data on the risk, potential need for hemostasis/coagulation testing, VTE prophylaxis, and therapeutic anticoagulation in patients with COVID-19 without confirmed/suspected thrombosis.",

author = "Barnes, {Geoffrey D.} and Adam Cuker and Gluckman, {Tyler J} and Gregory Piazza and Siegal, {Deborah M.}",

year = "2020",

month = apr,

day = "22",

language = "Undefined/Unknown",

series = "Articles, Abstracts, and Reports",

type = "Other",

}

TY - GEN

T1 - Feature | Thrombosis and COVID-19: FAQs For Current Practice

AU - Barnes, Geoffrey D.

AU - Cuker, Adam

AU - Gluckman, Tyler J

AU - Piazza, Gregory

AU - Siegal, Deborah M.

PY - 2020/4/22

Y1 - 2020/4/22

N2 - An FAQ on the potential impact of COVID-19 on thrombotic and/or bleeding risk from ACC's Science and Quality Committee summarize the current data on the risk, potential need for hemostasis/coagulation testing, VTE prophylaxis, and therapeutic anticoagulation in patients with COVID-19 without confirmed/suspected thrombosis.

AB - An FAQ on the potential impact of COVID-19 on thrombotic and/or bleeding risk from ACC's Science and Quality Committee summarize the current data on the risk, potential need for hemostasis/coagulation testing, VTE prophylaxis, and therapeutic anticoagulation in patients with COVID-19 without confirmed/suspected thrombosis.

M3 - Other contribution

T3 - Articles, Abstracts, and Reports

ER -